New Ebola Vaccine Shows Promise in Human Trials

March 25, 2015 4:00 PM

5 0

WEDNESDAY, March 25, 2015 (HealthDay News) -- An experimental Ebola vaccine shows promise in an early clinical trial, but requires much more testing, researchers report.

The trial included 120 healthy adults in China who received either a low or high dose of the vaccine, or a placebo. Twenty-eight days later, 38 of 40 people in the low-dose group and all 40 of those in the high-dose group showed an immune response to the vaccine.

Also read: U.S. fourth- and eighth-graders show gains on national science test

Read more

To category page